AstraZeneca, ZS Pharma overcome manufacturing issues to get potential blockbuster back on track

8 years ago

by David Miller

961 Views

Written by David Miller

AstraZeneca said its potential blockbuster hyperkalemia drug ZS-9 is back on track after the FDA rejected it in 2016 due to manufacturing issues at its Texas facility.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!